Tango Therapeutics Inc
TNGX
Market Cap$794.11M
Close$
$-6.30
184.6% downside
Current Fair Value
184.6% downsideOvervalued by 184.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $794.11 Million |
|---|---|
| Enterprise Value | $496.15 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.08 |
| Beta | 0.0 |
| Outstanding Shares | 106,735,395 |
| Avg 30 Day Volume | 508,860 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.81 |
|---|---|
| PEG | -133.18 |
| Price to Sales | - |
| Price to Book Ratio | 3.72 |
| Enterprise Value to Revenue | 13.58 |
| Enterprise Value to EBIT | -4.35 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
ESG Score
No data
About Tango Therapeutics Inc
4 employees